Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.

BACKGROUND AND AIMS The aim of this study was to determine the yield of endoscopic screening in first-degree relatives (FDRs) of CDH1-negative hereditary diffuse-type gastric cancer (HDGC) patients. METHODS In this retrospective observational cohort study, in 2 expert centers in the Netherlands data were collected on FDRs from families fulfilling the international HDGC criteria that underwent endoscopic screening. Extensive inspection of the stomach was performed by gastroscopy, taking random and/or targeted stomach biopsy specimens to identify diffuse-type gastric cancer. RESULTS Between 2004 and 2016, 90 persons (40% men; mean age, 48 years) from 40 families were offered endoscopic screening. The mean number of endoscopies per person was 3. The mean follow-up time was 46 months and mean endoscopic interval 20 months. Signet ring cell carcinoma foci restricted to the mucosa (pT1a) were identified in 4 persons (4%) from 1 family, which afterward was diagnosed with a germline CTNNA1 mutation. Advanced poorly cohesive gastric carcinoma was diagnosed in 1 person from another family. Intestinal metaplasia was diagnosed in 38 persons (42%) and low-grade dysplasia in 4 persons (4%). Additionally, in 40 persons (44%) scar tissue was observed in the gastric mucosa, which can hinder the endoscopic detection of small white lesions typical for HDGC. CONCLUSIONS Endoscopic screening in HDGC families without a pathogenic CDH1 mutation may be reasonable, as we detected signet ring cell carcinomas in 6% of persons screened. However, the criteria and frequency of screening may have to be reconsidered.

[1]  R. van Hillegersberg,et al.  Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers , 2015, Journal of Medical Genetics.

[2]  Joo Ha Hwang,et al.  Screening and surveillance for gastric cancer in the United States: Is it needed? , 2016, Gastrointestinal endoscopy.

[3]  M. Fukayama,et al.  Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. , 2016, Gastrointestinal endoscopy.

[4]  R. Jeffrey,et al.  A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer , 2011, Annals of Surgical Oncology.

[5]  J. Hwang,et al.  Gastric intestinal metaplasia: An irreversible risk factor for gastric cancer? , 2016, Gastrointestinal endoscopy.

[6]  B. Fernandez,et al.  Prophylactic Total Gastrectomy (PTG) for Hereditary Diffuse Gastric Cancer (HDGC): The Newfoundland Experience with 23 Patients , 2009, Annals of Surgical Oncology.

[7]  L. Vissers,et al.  Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing , 2017, European Journal of Human Genetics.

[8]  E. Kuipers,et al.  The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. , 2011, European journal of cancer.

[9]  D. Chung,et al.  Prophylactic total gastrectomy for individuals with germline CDH1 mutation. , 2011, Surgery.

[10]  H. Yoshida,et al.  Association of Helicobacter pylori and diffuse type gastric cancer. , 1996, Journal of gastroenterology.

[11]  Jing-Yuan Fang,et al.  Comparison of the clinicopathological characteristics of young and Elderly patients with gastric carcinoma: A meta analysis , 2012, Journal of surgical oncology.

[12]  M. Slattery,et al.  A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database. , 1993, JAMA.

[13]  L. Franzén,et al.  Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma , 2000, The British journal of surgery.

[14]  Randall W Burt,et al.  ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes , 2015, The American Journal of Gastroenterology.

[15]  T. Yoshimura,et al.  Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989 , 2001, British Journal of Cancer.

[16]  P. Guilford,et al.  Giant gastric ulcer: an endoscopic roller coaster , 2005, Gut.

[17]  R. Busuttil,et al.  Intestinal metaplasia: A premalignant lesion involved in gastric carcinogenesis , 2009, Journal of gastroenterology and hepatology.

[18]  J. Lennerz,et al.  Endoscopic Surveillance of Patients With Hereditary Diffuse Gastric Cancer: Biopsy Recommendations After Topographic Distribution of Cancer Foci in a Series of 10 CDH1-mutated Gastrectomies , 2012, The American journal of surgical pathology.

[19]  B. Fernandez,et al.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. , 2015, JAMA oncology.

[20]  A. Sézeur,et al.  CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study , 2013, Journal of Medical Genetics.

[21]  R. P. Blankfield,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[22]  J. Goldblatt,et al.  The Western Australian family connections genealogical project: detection of familial occurrences of single gene and chromosomal disorders. , 2014, Genetic Testing and Molecular Biomarkers.

[23]  A. Wagner,et al.  Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. , 2015, Gastroenterology.

[24]  E. Kuipers,et al.  Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. , 2008, Gastroenterology.

[25]  Takafumi Ando,et al.  Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: Data from a single institute over 30 years , 2007, Journal of gastroenterology and hepatology.

[26]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[27]  T. Hwang,et al.  Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger , 2012, Journal of surgical oncology.

[28]  C. Caldas,et al.  Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. , 2014, Gastrointestinal endoscopy.

[29]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[30]  A. Tavares,et al.  Analysis of Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young and Older Patients , 2012, Pathology & Oncology Research.

[31]  R. Bernards,et al.  An α‐E‐catenin (CTNNA1) mutation in hereditary diffuse gastric cancer , 2013, The Journal of pathology.

[32]  J. Coebergh,et al.  Gastric cancer: Decreasing incidence but stable survival in the Netherlands , 2014, Acta oncologica.

[33]  V. Moyer,et al.  Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. , 2011, Epidemiologic reviews.

[34]  J. Nattermann,et al.  Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients , 2016, Endoscopy International Open.